Sanofi SA
F:SNW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
F:SNW
|
FR |
|
Falcon Gold Corp
XTSX:FG
|
CA |
|
V
|
Vestas Wind Systems A/S
F:VWSB
|
DK |
|
T
|
TTL Beteiligungs und Grundbesitz AG
XMUN:TTO
|
DE |
|
J
|
JOYY Inc
DUS:0YYA
|
SG |
|
A
|
Alfa Laval AB
F:AA9
|
SE |
|
Molecular Templates Inc
NASDAQ:MTEM
|
US |
|
C
|
Chocoladefabriken Lindt & Spruengli AG
SWB:LSPP
|
CH |
|
M
|
MTY Food Group Inc
F:9MF
|
CA |
|
General de Alquiler de Maquinaria SA
MAD:GAM
|
ES |
|
Cronos Group Inc
TSX:CRON
|
CA |
|
M
|
Marubeni Corp
F:MARA
|
JP |
|
E
|
Evertec Inc
XMUN:2EV
|
PR |
|
B
|
Ball Corp
F:BL8
|
US |
|
B
|
Brown & Brown Inc
F:BTW
|
US |
|
Wartsila Oyj Abp
F:MTA
|
FI |
|
W
|
Westinghouse Air Brake Technologies Corp
F:WB2
|
US |
|
V
|
Vodafone Group PLC
F:VODI
|
UK |
|
W
|
Walmart Inc
XMUN:WMT
|
US |
|
E
|
EBR Systems Inc
ASX:EBR
|
US |
|
Abivax SA
F:2X1
|
FR |
Bankruptcy Probability
Sanofi SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sanofi SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Sanofi SA
PAR:SAN
|
91.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
643.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
318.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
222.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
137.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
49.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sanofi SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sanofi SA has total debt of 13.8B EUR. This includes both short-term (0 EUR) and long-term (13.8B EUR) debt.
You can find a full breakdown on its Balance Sheet.
